PERSPECTA

News from every angle

← Back to headlines

Eli Lilly's Incretin Portfolio Drives Continued Gains

Eli Lilly and Company (LLY) has seen continued financial gains, largely attributed to the strong performance of its incretin portfolio.

30 Mar, 13:31 — 30 Mar, 13:31
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual13d ago

Eli Lilly and Company (LLY) Continued to Gain from Its Incretin Portfolio

Read full article →

Related Stories

Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory

just now

Padel for Parkinson’s Cycling Event Held at University of Ghana for Awareness

10m ago

Understanding and Managing Postpartum Sweating

21m ago

Protecting Dogs from Viper Bites as Weather Warms

34m ago